Skip to main content
. 2022 Apr 21;14(9):2070. doi: 10.3390/cancers14092070

Figure 2.

Figure 2

Characterization of an in vitro induced core glioma stem cell model generated from glioblastoma patient-derived cells. (A) Workflow depicting the reprogramming of GBM-DCs into ic-GSC stable lines. (B) Immunostaining of OCT4, SOX2, NANOG, and HLA-ABC in GBM-DCs and three independent ic-GSC clones: ic-GSC#1, ic-GSC#3, and ic-GSC#7. Scale bars correspond to 50 µm.